Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 25,596 shares at $74.23 ($1.9M) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Seasonal sale ($1.9M) by CFO & Executive Vice President — this insider has traded RARE in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.23 | 10,234 | $760K | 40.0% |
| 2 | $74.23 | 10,234 | $760K | 40.0% |
| 3 | $74.01 | 2,564 | $190K | 10.0% |
| 4 | $74.01 | 2,564 | $190K | 10.0% |
| Total | $74.19 avg | 25,596 | $1.9M | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |
| RARE | SELL | 2019-04-17 | $133K | — | Filing → |